Advertisement
MO BIO
MO BIO

Critic at Large

» policy, regulation and science policy

Most Recent

image: Overspending on Overhead

Overspending on Overhead

By | February 1, 2015

Federal research dollars are needlessly wasted as scientists spend more and more of their time trying to recoup operational costs.

5 Comments

image: Psychiatry: An SOS Call

Psychiatry: An SOS Call

By | May 1, 2014

Social policies shaped the practice of psychiatry in the past. As the discipline becomes ever more scientific, the effects of social policy on patient well-being must not be ignored.

0 Comments

image: The Great Divide

The Great Divide

By | December 1, 2013

A two-way bridge between science and policy is desperately needed.

2 Comments

image: Proceed with Caution

Proceed with Caution

By | October 1, 2013

While genomic data sharing is essential for research, scientists must work to keep sensitive, potentially damaging information under wraps.

1 Comment

image: Border Buffers

Border Buffers

By | April 1, 2013

Protected areas help to conserve imperiled tropical forests, but many are struggling to sustain their resident species.

0 Comments

image: DIYbio: Low Risk, High Potential

DIYbio: Low Risk, High Potential

By | March 1, 2013

Citizen scientists can inspire innovation and advance science education—and they are proving adept at self-policing.

5 Comments

image: Regulating Amateurs

Regulating Amateurs

By | March 1, 2013

How should the government ensure the safety and responsibility of do-it-yourself biologists?

2 Comments

image: Medicines for the World

Medicines for the World

By | October 1, 2012

A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.

0 Comments

image: Science and Democracy

Science and Democracy

By | October 1, 2012

Researchers and conscientious citizens must unite against the partisan rancor in American politics and restore the role of scientific information in policymaking.

1 Comment

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

Advertisement
Horizon Discovery
Horizon Discovery

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

Advertisement
Advertisement
Advertisement
Life Technologies